Clinical trial
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive…
NCT00413218 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00413218 |
|---|---|
| Title | Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections |
| Official title | A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Basilea Pharmaceutica Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Candidiasis, Invasive, Candidemia, Mycoses |
| Intervention type | Drug |
| Interventions | Isavuconazole, Caspofungin, Voriconazole |
| Enrollment | 450 |
| Start date | Mar 8, 2007 |
| Primary completion | Mar 3, 2015 |
| Completion | Mar 3, 2015 |
| First posted | Dec 19, 2006 |
| Last update posted | Dec 10, 2024 |
| Countries | Argentina, Australia, Belgium, Brazil, Canada, Chile, China, France, Germany, Hungary, India, Israel and 13 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: